Rigel Pharmaceuticals Inc SEC filings RIGL

Rigel Pharmaceuticals Inc has 1,002 filings in SEC EDGAR's recent list, going back to Nov 6, 2007. Its latest annual report, Form 10-K, was filed on Mar 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Rigel Pharmaceuticals Inc SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
S-8 Employee stock plan registration Aug 4, 2026 —
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Officer or director change
Jul 1, 2026 Jun 25, 2026
8-K Current report
Acquisition or sale of assets
Jun 17, 2026 Jun 11, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 20, 2026 May 14, 2026
8-K Current report
Material agreement
May 12, 2026 May 11, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Agreement ended
Apr 21, 2026 Apr 16, 2026
DEFA14A Additional proxy material Apr 3, 2026 —
DEF 14A Proxy statement Apr 3, 2026 May 14, 2026
8-K Current report
Results of operations
Mar 3, 2026 Mar 3, 2026
10-K Annual report Mar 3, 2026 Dec 31, 2025
8-K Current report
Officer or director change
Feb 3, 2026 Feb 1, 2026
8-K Current report
Results of operations, Other events
Jan 12, 2026 Jan 12, 2026
8-K Current report
Other events
Dec 10, 2025 Dec 7, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
S-8 Employee stock plan registration Aug 6, 2025 —
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
8-K Current report
Officer or director change, Shareholder vote results
May 23, 2025 May 22, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
ARS Annual report to shareholders Apr 10, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 10, 2025 —
DEF 14A Proxy statement Apr 10, 2025 May 22, 2025
8-K Current report
Other events
Mar 27, 2025 Mar 27, 2025
8-K Current report
Officer or director change
Mar 10, 2025 Mar 6, 2025
8-K Current report
Results of operations
Mar 4, 2025 Mar 4, 2025
10-K Annual report Mar 4, 2025 Dec 31, 2024
8-K Current report
Results of operations, Other events
Jan 13, 2025 Jan 13, 2025
8-K Current report
Other events
Dec 9, 2024 Dec 9, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Officer or director change
Sep 19, 2024 Sep 16, 2024
8-K Current report
Material agreement
Sep 3, 2024 Sep 3, 2024
EFFECT Filing Aug 9, 2024 —
CORRESP Letter to the SEC Aug 8, 2024 —
UPLOAD Letter from the SEC Aug 7, 2024 —
S-8 Employee stock plan registration Aug 6, 2024 —
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
S-3 Shelf registration Aug 2, 2024 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jun 27, 2024 Jun 27, 2024
8-K Current report
Other events
Jun 25, 2024 Jun 25, 2024
8-K Current report
Officer or director change, Shareholder vote results
May 29, 2024 May 24, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Material agreement
Apr 12, 2024 Apr 11, 2024
ARS Annual report to shareholders Apr 10, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 10, 2024 —
DEF 14A Proxy statement Apr 10, 2024 May 22, 2024
PRE 14A Preliminary proxy statement Mar 29, 2024 May 22, 2024
8-K Current report
Results of operations
Mar 5, 2024 Mar 5, 2024
10-K Annual report Mar 5, 2024 Dec 31, 2023
8-K Current report
Material agreement, Acquisition or sale of assets
Feb 22, 2024 Feb 22, 2024
8-K Current report
Results of operations, Other events
Jan 8, 2024 Jan 8, 2024
8-K Current report
Listing notice
Nov 30, 2023 Nov 27, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
S-8 Employee stock plan registration Aug 1, 2023 —
8-K Current report
Results of operations
Aug 1, 2023 Aug 1, 2023
10-Q Quarterly report Aug 1, 2023 Jun 30, 2023
8-K Current report
Officer or director change, Shareholder vote results
May 30, 2023 May 25, 2023
DEFR14A Defr 14a May 15, 2023 —
8-K Current report
Results of operations
May 2, 2023 May 2, 2023
10-Q Quarterly report May 2, 2023 Mar 31, 2023
ARS Annual report to shareholders Apr 14, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 14, 2023 —
DEF 14A Proxy statement Apr 14, 2023 —
S-8 Employee stock plan registration Mar 7, 2023 —
8-K Current report
Results of operations
Mar 7, 2023 Mar 7, 2023
10-K Annual report Mar 7, 2023 Dec 31, 2022
8-K Current report
Officer or director change
Feb 3, 2023 Feb 1, 2023
8-K Current report
Results of operations, Other events
Jan 9, 2023 Jan 9, 2023
8-K Current report
Other events
Dec 2, 2022 Dec 1, 2022
8-K Current report
Listing notice
Nov 29, 2022 Nov 22, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Material agreement, Results of operations, Bylaw or fiscal year change
Nov 3, 2022 Oct 28, 2022
8-K Current report
Other events
Nov 1, 2022 Nov 1, 2022
8-K Current report
Exit or restructuring costs, Officer or director change, Other events
Oct 11, 2022 Oct 10, 2022
S-8 Employee stock plan registration Aug 3, 2022 —
8-K Current report
Material agreement, Results of operations, New debt
Aug 2, 2022 Jul 27, 2022
10-Q Quarterly report Aug 2, 2022 Jun 30, 2022
8-K Current report
Other events
Jul 25, 2022 Jul 25, 2022
8-K Current report
Other events
Jun 23, 2022 Jun 23, 2022
8-K Current report
Other events
Jun 8, 2022 Jun 8, 2022
8-K Current report
Officer or director change, Shareholder vote results
May 23, 2022 May 19, 2022
EFFECT Filing May 3, 2022 —
8-K Current report
Results of operations
May 3, 2022 May 3, 2022
10-Q Quarterly report May 3, 2022 Mar 31, 2022
DEFA14A Additional proxy material Apr 5, 2022 —
DEF 14A Proxy statement Apr 5, 2022 May 19, 2022
S-8 Employee stock plan registration Mar 1, 2022 —
POS AM Filing Mar 1, 2022 —
8-K Current report
Results of operations
Mar 1, 2022 Mar 1, 2022
10-K Annual report Mar 1, 2022 Dec 31, 2021
POSASR Filing Mar 1, 2022 —
8-K Current report
Material agreement, New debt
Feb 17, 2022 Feb 11, 2022
8-K Current report
Officer or director change
Jan 28, 2022 Jan 27, 2022
8-K Current report
Results of operations, Other events
Jan 10, 2022 Jan 10, 2022
8-K Current report
Officer or director change
Dec 17, 2021 Dec 16, 2021
8-K Current report
Exit or restructuring costs
Nov 15, 2021 Nov 12, 2021
8-K Current report
Results of operations
Nov 2, 2021 Nov 2, 2021
10-Q Quarterly report Nov 2, 2021 Sep 30, 2021
8-K Current report
Other events
Aug 13, 2021 Aug 13, 2021
S-3ASR Automatic shelf registration Aug 3, 2021 —
8-K Current report
Results of operations
Aug 3, 2021 Aug 3, 2021
10-Q Quarterly report Aug 3, 2021 Jun 30, 2021
S-8 Employee stock plan registration Jun 21, 2021 —
8-K Current report
Officer or director change, Shareholder vote results
May 21, 2021 May 18, 2021
8-K Current report
Officer or director change
May 14, 2021 May 13, 2021
10-Q Quarterly report May 5, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 5, 2021 May 5, 2021
8-K Current report
Other events
Apr 13, 2021 Apr 13, 2021
DEF 14A Proxy statement Apr 6, 2021 May 18, 2021
10-K Annual report Mar 2, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 2, 2021 Mar 2, 2021
8-K Current report
Material agreement
Feb 18, 2021 Feb 18, 2021
8-K Current report
Officer or director change
Feb 3, 2021 Jan 28, 2021
8-K Current report
Results of operations
Jan 11, 2021 Jan 11, 2021
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Officer or director change
Oct 8, 2020 Oct 2, 2020
S-8 Employee stock plan registration Aug 4, 2020 —
424B5 Prospectus supplement Aug 4, 2020 —
10-Q Quarterly report Aug 4, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 4, 2020 Aug 4, 2020
8-K Current report
Officer or director change, Shareholder vote results
May 15, 2020 May 14, 2020
8-K Current report
Results of operations
May 5, 2020 May 5, 2020
10-Q Quarterly report May 5, 2020 Mar 31, 2020
DEFA14A Additional proxy material May 1, 2020 —
CT ORDER Filing Apr 24, 2020 —
CT ORDER Filing Apr 24, 2020 —
DEFA14A Additional proxy material Apr 1, 2020 —
DEF 14A Proxy statement Apr 1, 2020 May 14, 2020
8-K Current report
Results of operations
Feb 27, 2020 Feb 27, 2020
10-K Annual report Feb 27, 2020 Dec 31, 2019
SEC STAFF LETTER Filing Feb 18, 2020 —
SEC STAFF LETTER Filing Feb 5, 2020 —
CT ORDER Filing Jan 16, 2020 —
CT ORDER Filing Jan 16, 2020 —
CT ORDER Filing Jan 16, 2020 —
8-K Current report
Results of operations
Jan 13, 2020 Jan 13, 2020
8-K Current report
Officer or director change
Dec 17, 2019 Dec 16, 2019
8-K Current report
Officer or director change
Nov 22, 2019 Nov 20, 2019
8-K Current report
Other events
Nov 18, 2019 Nov 15, 2019
10-Q Quarterly report Nov 5, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 5, 2019 Nov 5, 2019
8-K Current report
Results of operations, Other events
Oct 23, 2019 Oct 18, 2019
8-K Current report
Material agreement, New debt, Change to shareholder rights
Oct 2, 2019 Sep 27, 2019
S-8 Employee stock plan registration Aug 7, 2019 —
8-K Current report
Results of operations
Aug 6, 2019 Aug 6, 2019
10-Q Quarterly report Aug 6, 2019 Jun 30, 2019
8-K Current report
Officer or director change, Shareholder vote results
May 24, 2019 May 22, 2019
8-K Current report
Officer or director change
May 16, 2019 May 15, 2019
8-K Current report
Results of operations
May 7, 2019 May 7, 2019
10-Q Quarterly report May 7, 2019 Mar 31, 2019
DEFA14A Additional proxy material Apr 9, 2019 —
DEF 14A Proxy statement Apr 9, 2019 May 22, 2019
8-K Current report
Officer or director change
Mar 26, 2019 Mar 22, 2019
CT ORDER Filing Mar 20, 2019 —
8-K Current report
Results of operations
Feb 28, 2019 Feb 28, 2019
10-K Annual report Feb 28, 2019 Dec 31, 2018
8-K Current report
Officer or director change
Feb 1, 2019 Jan 31, 2019
8-K Current report
Material agreement
Jan 23, 2019 Jan 22, 2019
8-K Current report
Results of operations
Jan 7, 2019 Jan 7, 2019
8-K Current report
Results of operations
Nov 6, 2018 Nov 6, 2018
10-Q Quarterly report Nov 6, 2018 Sep 30, 2018
8-K Current report
Material agreement
Oct 29, 2018 Oct 26, 2018
8-K Current report
Regulation FD disclosure
Oct 4, 2018 Oct 4, 2018
S-8 Employee stock plan registration Aug 8, 2018 —
8-K Current report
Results of operations
Aug 8, 2018 Aug 8, 2018
10-Q Quarterly report Aug 8, 2018 Jun 30, 2018
8-K Current report
Officer or director change
May 31, 2018 May 24, 2018
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
May 18, 2018 May 16, 2018
8-K Current report
Results of operations
May 1, 2018 May 1, 2018
10-Q Quarterly report May 1, 2018 Mar 31, 2018
8-K Current report
Results of operations, Other events
Apr 20, 2018 Apr 18, 2018
424B5 Prospectus supplement Apr 20, 2018 —
424B5 Prospectus supplement Apr 18, 2018 —
DEFA14A Additional proxy material Apr 4, 2018 —
DEF 14A Proxy statement Apr 4, 2018 May 16, 2018
EFFECT Filing Apr 2, 2018 —
CORRESP Letter to the SEC Apr 2, 2018 —
10-K/A Amended annual report Mar 29, 2018 Dec 31, 2017
PRE 14A Preliminary proxy statement Mar 23, 2018 May 16, 2018
UPLOAD Letter from the SEC Mar 19, 2018 —
CT ORDER Filing Mar 15, 2018 —
S-3 Shelf registration Mar 9, 2018 —
8-K Current report
Results of operations
Mar 6, 2018 Mar 6, 2018
10-K Annual report Mar 6, 2018 Dec 31, 2017
8-K Current report
Officer or director change
Feb 2, 2018 Feb 1, 2018
8-K Current report
Officer or director change
Jan 26, 2018 Jan 24, 2018
8-K Current report
Results of operations
Jan 4, 2018 Jan 4, 2018
8-K Current report
Officer or director change
Dec 15, 2017 Dec 11, 2017

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RIGL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Accelerated filer
SEC CIK
1034842
Former names
RIGEL PHARMACEUTICALS INC (until Nov 5, 2026)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.